Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer

Published:2016-09 Issue:3 Volume:207 Page:W26-W32
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Kim Jung Hoon,Joo Ijin,Kim Tae-Yong,Han Sae-Won,Kim Yong Jae,Lee Jeong Min,Han Joon Koo

Publisher

American Roentgen Ray Society

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference30 articles.

1. Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

2. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

3. Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

4. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases

5. Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant Chemotherapy

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reproducibility of intravoxel incoherent motion quantification in the liver across field strengths and gradient hardware;Magnetic Resonance in Medicine;2024-08-09

2. Retrospective Motion Artifact Reduction by Spatial Scaling of Liver Diffusion-Weighted Images;Tomography;2023-10-06

3. Liver metastases: The role of magnetic resonance imaging;World Journal of Gastroenterology;2023-09-28

4. MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423);Cancers;2023-07-12

5. Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy;Hepatology Research;2023-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3